HIGHLIGHTS
- who: Mengjin Hu et al. from the State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases have published the research: The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent, in the Journal: (JOURNAL)
- what: Among patients treated with DESs, 3-month DAPT followed by P2Y12 inhibitor monotherapy reduced the risks of net clinical events and bleeding events without increasing ischemic events, and the benefits were consistent for male patients with ACS, complex lesions, single-vessel disease, young age, and low BMI.
- how: Since . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.